|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM241455235 |
003 |
DE-627 |
005 |
20231224124305.0 |
007 |
cr uuu---uuuuu |
008 |
231224s2014 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2014.08.008
|2 doi
|
028 |
5 |
2 |
|a pubmed24n0804.xml
|
035 |
|
|
|a (DE-627)NLM241455235
|
035 |
|
|
|a (NLM)25173800
|
035 |
|
|
|a (PII)S1521-6616(14)00199-5
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Sfikakis, P P
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Cadherin-11 mRNA transcripts are frequently found in rheumatoid arthritis peripheral blood and correlate with established polyarthritis
|
264 |
|
1 |
|c 2014
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 26.01.2015
|
500 |
|
|
|a Date Revised 02.11.2020
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Copyright © 2014 Elsevier Inc. All rights reserved.
|
520 |
|
|
|a Rheumatoid arthritis (RA) synovial fibroblasts hyperexpress the mesenchymal cadherin-11, which is involved also in tumor invasion/metastasis, whereas anti-cadherin-11 therapeutics prevent and reduce experimental arthritis. To test the hypothesis that cadherin-11 is aberrantly expressed in RA peripheral blood, 100 patients (15 studied serially) and 70 healthy controls were analyzed by real-time reverse transcription-PCR. Cadherin-11 mRNA transcripts were detected in 69.2% of moderately/severely active RA, versus 31.8% of remaining patients (p=0.001), versus 17.1% of controls (p<0.0001). Notably, cadherin-11 positivity correlated significantly and independently only with established (>1year) polyarthritis (>4 swollen tender joints), by multivariate logistic regression analysis including various possible clinical/laboratory factors. Rare cells of undefined nature, detected by flow cytometry following CD45(-) enrichment, strongly expressed surface cadherin-11 (estimated 10-50cells/ml of blood) in 5/6 patients with polyarticular established disease versus 1/6 patients with early RA. Studies on the potential pathogenic role of circulating cells expressing cadherin-11 in RA are warranted
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Biomarker
|
650 |
|
4 |
|a Cadherin-11
|
650 |
|
4 |
|a Peripheral blood
|
650 |
|
4 |
|a Polyarthritis
|
650 |
|
4 |
|a Rheumatoid arthritis
|
650 |
|
4 |
|a Synovial fibroblast
|
650 |
|
7 |
|a Cadherins
|2 NLM
|
650 |
|
7 |
|a RNA, Messenger
|2 NLM
|
650 |
|
7 |
|a osteoblast cadherin
|2 NLM
|
650 |
|
7 |
|a 156621-71-5
|2 NLM
|
700 |
1 |
|
|a Christopoulos, P F
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Vaiopoulos, A G
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Fragiadaki, K
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Katsiari, C
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Kapsimali, V
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Lallas, G
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Panayiotidis, P
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Korkolopoulou, P
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Koutsilieris, M
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 155(2014), 1 vom: 28. Nov., Seite 33-41
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:155
|g year:2014
|g number:1
|g day:28
|g month:11
|g pages:33-41
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2014.08.008
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 155
|j 2014
|e 1
|b 28
|c 11
|h 33-41
|